References
Schröder FH, Hugosson J, Roobol MJ et al (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360:1320–1328
Andriole GL, Grubb RL III, Buys SS et al (2009) Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360:1310–1319
Berry MJ (2009) Screening for prostate cancer—the controversy that refuses to die. N Engl J Med 360:1351–1354
Gilligan T (2009) The new data on prostate cancer screening: what should we do now? Clevel Clin J Med 76:446–448
Klein EA (2009) What’s new in prostate cancer screening and prevention? Clevel Clin J Med 76:439–445
Ablin RJ, Haythron MR (2009) Screening for prostate cancer: controversy? What controversy? Curr Oncol 16:1–2
Dubben HH (2009) Correspondence: prostate cancer screening. N Engl J Med 361:202–206
Berry MJ, Mulley AJ (2009) Why are high overdiagnosis probability and lead time for prostate cancer screening so important? JNCI 101:362–363
Bill-Axelson A, Holmberg L, Ruutu M et al (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. New Engl J Med 352:1977–1984
Wilt TJ, Brawer MK, Barry MJ et al (2009) The prostate cancer intervention versus observation trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer. Contemp Clin Trials 30:81–87
Donovan J, Hamdy F, Neal D et al (2003) Prostate testing for cancer and treatment (ProtecT) feasibility study. Health Technol Assess 7:1–88
Martin RM, Donovan JL, Hamdy FC et al (2009) Evaluating population-based screening for localized prostate cancer in the United Kingdom: the CAP (Comparison Arm for ProtecT) study. Cancer Research UK/Department of Health (C18281/A8145), London. http://ije.oxfordjournals.org/cgi/content/full/dyl305v1. Accessed 6 Mar 2009
Rosser CJ (2008) Prostate cancer—to screen, or not to screen, is that the question? BMC Urology 8:20–22
NCI—Prostate cancer screening (PDQ) (2009). http://www.canc.gov. Last update 27 Jul 2009
US Preventive Services Task Force (2008) Screening for prostate cancer: US preventive services task force recommendation statement. Ann Int Med 149:185–191
Lin K, Lipsitz R, Miller T et al (2008) Benefit and harms of Prostate-Specific Antigen Screening for prostate cancer: an evidence update for the US Preventive Services Task Force. Ann Int Med 149:192–199
NCCN Clinical practice guidelines in oncology—prostate cancer early detection (2009). http://www.nccn.org version 2/2010
AUA (American Urological Association). Prostate Cancer Screening (2009). http://www.AUAnet.org/guidelines. Last update Apr 2009
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sciallero, S., Fornarini, G. Prostate cancer screening with PSA: new data, old debate. Oncol Rev 3, 133–135 (2009). https://doi.org/10.1007/s12156-009-0024-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12156-009-0024-5